1-20 of 23
Wu Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial

Yajin Chen, Chengyou Du, Shunli Shen, Wu Zhang, Yunfeng Shan, Ang Lyu, Jianhui Wu, Changzhen Shang, Xuan Luo, Jinxing Wei, Heng Xiao, Jianguo Qiu, Yunpeng Hua, Shutong Wang, Ting Wang, Shengjie Dai, Shuhao Zhang, Bingying Xie, Yinghao Wu, Chunyi Hao
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (14): 2937–2944.
https://doi.org/10.1158/1078-0432.CCR-24-0006
Published: 15 July 2024
View articletitled, Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial
Open the PDF for Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial in another window
Includes: Supplementary data
Journal Articles

Editor's Note: Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and its Nuclear Accumulation Suppresses Gastric Tumorigenesis

Longlong Cao, Jiechao Zhou, Junrong Zhang, Sijin Wu, Xintao Yang, Xin Zhao, Huifang Li, Ming Luo, Qian Yu, Guangtan Lin, Huizhong Lin, Jianwei Xie, Ping Li, Xiaoqing Hu, Chaohui Zheng, Guojun Bu, Yun-wu Zhang, Huaxi Xu, Yongliang Yang, Changming Huang, Jie Zhang
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (4): 918.
https://doi.org/10.1158/1078-0432.CCR-23-3968
Published: 16 February 2024
View articletitled, Editor's Note: Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and its Nuclear Accumulation Suppresses Gastric Tumorigenesis
Open the PDF for Editor's Note: Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and its Nuclear Accumulation Suppresses Gastric Tumorigenesis in another window
Journal Articles

The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer

Hiroyuki Arai, Andrew Elliott, Joanne Xiu, Jingyuan Wang, Francesca Battaglin, Natsuko Kawanishi, Shivani Soni, Wu Zhang, Joshua Millstein, Davendra Sohal, Richard M. Goldberg, Michael J. Hall, Aaron J. Scott, Moh'd Khushman, Jimmy J. Hwang, Emil Lou, Benjamin A. Weinberg, John L. Marshall, Albert C. Lockhart, Phillip Stafford, Jian Zhang, Roberto Moretto, Chiara Cremolini, W. Michael Korn, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (11): 3234–3242.
https://doi.org/10.1158/1078-0432.CCR-20-3635
Published: 01 June 2021
View articletitled, The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
Open the PDF for The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)

Alberto Puccini, Kelsey Poorman, Mohamed E. Salem, Davide Soldato, Andreas Seeber, Richard M. Goldberg, Anthony F. Shields, Joanne Xiu, Francesca Battaglin, Martin D. Berger, Ryuma Tokunaga, Madiha Naseem, Afsaneh Barzi, Syma Iqbal, Wu Zhang, Shivani Soni, Jimmy J. Hwang, Philip A. Philip, Stefania Sciallero, W. Michael Korn, John L. Marshall, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (22): 5943–5951.
https://doi.org/10.1158/1078-0432.CCR-20-1804
Published: 13 November 2020
View articletitled, Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
Open the PDF for Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) in another window
Journal Articles

TRIB3 Stabilizes High TWIST1 Expression to Promote Rapid APL Progression and ATRA Resistance

Jian Lin, Wu Zhang, Li-Ting Niu, Yong-Mei Zhu, Xiang-Qin Weng, Yan Sheng, Jiang Zhu, Jie Xu
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (20): 6228–6242.
https://doi.org/10.1158/1078-0432.CCR-19-0510
Published: 15 October 2019
View articletitled, TRIB3 Stabilizes High TWIST1 Expression to Promote Rapid APL Progression and ATRA Resistance
Open the PDF for TRIB3 Stabilizes High TWIST1 Expression to Promote Rapid APL Progression and ATRA Resistance in another window
Includes: Supplementary data
Journal Articles

Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer

Ryuma Tokunaga, Joanne Xiu, Curtis Johnston, Richard M. Goldberg, Philip A. Philip, Andreas Seeber, Madiha Naseem, Jae Ho Lo, Hiroyuki Arai, Francesca Battaglin, Alberto Puccini, Martin D. Berger, Shivani Soni, Wu Zhang, Jimmy J. Hwang, Anthony F. Shields, John L. Marshall, Hideo Baba, W. Michael Korn, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (10): 3096–3103.
https://doi.org/10.1158/1078-0432.CCR-18-3388
Published: 15 May 2019
View articletitled, Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer
Open the PDF for Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab

Martin D. Berger, Sebastian Stintzing, Volker Heinemann, Shu Cao, Dongyun Yang, Yu Sunakawa, Satoshi Matsusaka, Yan Ning, Satoshi Okazaki, Yuji Miyamoto, Mitsukuni Suenaga, Marta Schirripa, Diana L. Hanna, Shivani Soni, Alberto Puccini, Wu Zhang, Chiara Cremolini, Alfredo Falcone, Fotios Loupakis, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (4): 784–793.
https://doi.org/10.1158/1078-0432.CCR-17-1663
Published: 14 February 2018
View articletitled, A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab
Open the PDF for A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab in another window
Includes: Supplementary data
Journal Articles

Molecular Pathways: Cachexia Signaling—A Targeted Approach to Cancer Treatment

Yuji Miyamoto, Diana L. Hanna, Wu Zhang, Hideo Baba, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16): 3999–4004.
https://doi.org/10.1158/1078-0432.CCR-16-0495
Published: 14 August 2016
View articletitled, Molecular Pathways: Cachexia Signaling—A Targeted Approach to Cancer Treatment
Open the PDF for Molecular Pathways: Cachexia Signaling—A Targeted Approach to Cancer Treatment in another window
Journal Articles

Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy

Satoshi Matsusaka, Diana L. Hanna, Shu Cao, Wu Zhang, Dongyun Yang, Yan Ning, Yu Sunakawa, Satoshi Okazaki, Martin D. Berger, Yuji Miyamato, Anish Parekh, Sebastian Stintzing, Fotios Loupakis, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (13): 3218–3226.
https://doi.org/10.1158/1078-0432.CCR-15-2422
Published: 30 June 2016
View articletitled, Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy
Open the PDF for Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation

Pierre Bohanes, Cathryn J. Rankin, Charles D. Blanke, Thomas Winder, Cornelia M. Ulrich, Stephen R. Smalley, Tyvin A. Rich, James A. Martensen, Al B. Benson, III, Robert J. Mayer, Christine M. Cripps, Kathleen Danenberg, Karen W. Makar, Wu Zhang, Jacqueline K. Benedetti, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (7): 1583–1590.
https://doi.org/10.1158/1078-0432.CCR-14-0857
Published: 31 March 2015
View articletitled, Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation
Open the PDF for Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation in another window
Journal Articles

Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and Its Nuclear Accumulation Suppresses Gastric Tumorigenesis

Longlong Cao, Jiechao Zhou, Junrong Zhang, Sijin Wu, Xintao Yang, Xin Zhao, Huifang Li, Ming Luo, Qian Yu, Guangtan Lin, Huizhong Lin, Jianwei Xie, Ping Li, Xiaoqing Hu, Chaohui Zheng, Guojun Bu, Yun-wu Zhang, Huaxi Xu, Yongliang Yang, Changming Huang, Jie Zhang
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (6): 1419–1428.
https://doi.org/10.1158/1078-0432.CCR-14-1950
Published: 12 March 2015
View articletitled, Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and Its Nuclear Accumulation Suppresses Gastric Tumorigenesis
Open the PDF for Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and Its Nuclear Accumulation Suppresses Gastric Tumorigenesis in another window
Includes: Supplementary data
Journal Articles

A let-7 microRNA-Binding Site Polymorphism in KRAS Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab Monotherapy

Zenia Saridaki, Joanne B. Weidhaas, Heinz-Josef Lenz, Pierre Laurent-Puig, Bart Jacobs, Jef De Schutter, Wendy De Roock, David W. Salzman, Wu Zhang, Dongyun Yang, Camilla Pilati, Olivier Bouché, Hubert Piessevaux, Sabine Tejpar
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (17): 4499–4510.
https://doi.org/10.1158/1078-0432.CCR-14-0348
Published: 01 September 2014
View articletitled, A let-7 microRNA-Binding Site Polymorphism in KRAS Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab Monotherapy
Open the PDF for A let-7 microRNA-Binding Site Polymorphism in KRAS Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab Monotherapy in another window
Includes: Supplementary data
Journal Articles

Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence

David Páez, Melissa J. Labonte, Pierre Bohanes, Wu Zhang, Leonor Benhanim, Yan Ning, Takeru Wakatsuki, Fotios Loupakis, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3): 645–653.
https://doi.org/10.1158/1078-0432.CCR-11-2186
Published: 31 January 2012
View articletitled, Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence
Open the PDF for Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence in another window
Journal Articles

Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence

Armin Gerger, Wu Zhang, Dongyun Yang, Pierre Bohanes, Yan Ning, Thomas Winder, Melissa J. LaBonte, Peter M. Wilson, Leonor Benhaim, David Paez, Rita El-Khoueiry, Anthony El-Khoueiry, Michael Kahn, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (21): 6934–6943.
https://doi.org/10.1158/1078-0432.CCR-11-1180
Published: 31 October 2011
View articletitled, Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence
Open the PDF for Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence in another window
Journal Articles

Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer

Armin Gerger, Anthony El-Khoueiry, Wu Zhang, Dongyun Yang, Harpreet Singh, Pierre Bohanes, Yan Ning, Thomas Winder, Melissa J. LaBonte, Peter M. Wilson, Leonor Benhaim, David Paez, Rita El-Khoueiry, Gudrun Absenger, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (17): 5783–5792.
https://doi.org/10.1158/1078-0432.CCR-11-1115
Published: 01 September 2011
View articletitled, Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
Open the PDF for Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients

Siwen Hu-Lieskovan, Daniel Vallbohmer, Wu Zhang, Dongyun Yang, Alexander Pohl, Melissa J. Labonte, Peter P. Grimminger, Arnulf H. Hölscher, Robert Semrau, Dirk Arnold, Kathrin Dellas, Annelies Debucquoy, Karin Haustermans, Jean-Pascal H. Machiels, Christine Sempoux, Claus Rödel, Matej Bracko, Vaneja Velenik, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 5161–5169.
https://doi.org/10.1158/1078-0432.CCR-10-2666
Published: 31 July 2011
View articletitled, EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients
Open the PDF for EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients in another window
Journal Articles

Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients

Thomas Winder, Wu Zhang, Dongyun Yang, Yan Ning, Pierre Bohanes, Armin Gerger, Peter M. Wilson, Alexandra Pohl, David J. Mauro, Christiane Langer, Eric K. Rowinsky, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (22): 5591–5602.
https://doi.org/10.1158/1078-0432.CCR-10-2092
Published: 14 November 2010
View articletitled, Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients
Open the PDF for Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients in another window
Journal Articles

Gender Disparities in Metastatic Colorectal Cancer Survival

Andrew Hendifar, Dongyun Yang, Felicitas Lenz, Georg Lurje, Alexandra Pohl, Cosima Lenz, Yan Ning, Wu Zhang, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (20): 6391–6397.
https://doi.org/10.1158/1078-0432.CCR-09-0877
Published: 14 October 2009
View articletitled, Gender Disparities in Metastatic Colorectal Cancer Survival
Open the PDF for Gender Disparities in Metastatic Colorectal Cancer Survival in another window
Journal Articles

Polymorphisms in Cyclooxygenase-2 and Epidermal Growth Factor Receptor Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab

Georg Lurje, Fumio Nagashima, Wu Zhang, Dongyun Yang, Heung M. Chang, Michael A. Gordon, Anthony El-Khoueiry, Hatim Husain, Peter M. Wilson, Robert D. Ladner, David J. Mauro, Christiane Langer, Eric K. Rowinsky, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (23): 7884–7895.
https://doi.org/10.1158/1078-0432.CCR-07-5165
Published: 01 December 2008
View articletitled, Polymorphisms in Cyclooxygenase-2 and Epidermal Growth Factor Receptor Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab
Open the PDF for Polymorphisms in Cyclooxygenase-2 and Epidermal Growth Factor Receptor Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab in another window
Journal Articles

Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab

Anne M. Schultheis, Georg Lurje, Katrin E. Rhodes, Wu Zhang, Dongyun Yang, Agustin A. Garcia, Robert Morgan, David Gandara, Sidney Scudder, Amit Oza, Hal Hirte, Gini Fleming, Lynda Roman, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (22): 7554–7563.
https://doi.org/10.1158/1078-0432.CCR-08-0351
Published: 14 November 2008
View articletitled, Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab
Open the PDF for Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab in another window
Includes: Supplementary data